Clinical Trials

Microscopy image of a tumor section (obtained from a mouse tumor model) shows the blue-stained nanoparticles selectively accumulating in the peripheral tumor area and then penetrating into tumor cells

Exploring the Effectiveness of an Experimental Class of Drug

Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?

Illustration of the DNA double helix in red, blue, purple, yellow, orange, and green. There is a main spiral in the center and two faded spirals on the left and right.

Using a Colon Cancer Drug to Treat Advanced Pancreatic Cancer

A clinical trial tests the effectiveness of an approved colon cancer drug against advanced pancreatic neuroendocrine cancer.

Clear cylinders--test tubes--with somethiing tan-colored in each plus a liquid, against a blue background. Other lab glassware pieces are visible in the background.

Maintenance Chemotherapy Trial for Pancreatic Cancer Patients with the BRCA Mutation

A clinical trial for patients with BRCA mutations uses a PARP inhibitor as part of the maintenance chemotherapy experimental treatment.

Microscope image of a yellow cell with white cells around it and partly reaching on it, on a teal background

Testing the Effect of a Malaria Drug on Standard Treatment

A clinical trial tests whether a malaria drug can make standard chemotherapy for advanced pancreatic cancer more effective.

illustration of the DNA double helix in purple and dark gray on a turquoise background

Discovering the Better Drug Treatment After Surgery for Pancreatic Cancer

A clinical trial compares two chemotherapy regimens to see which one is more effective at knocking out remaining cancer cells.

Close up photo of a microscope in grays and blues

Exploring the Better Treatment for Stable Metastatic Pancreatic Cancer

For patients with stable metastatic pancreatic cancer, a clinical trial compares standard chemotherapy with immunotherapy.

A rack of many purple transparent cylinders.

Patients Needed for Clinical Trial/Research Study of Treatment Targeting Immune System

A clinical trial seeks pancreatic cancer patients with the MSI (microsatellite instability) genetic signature, to test an immunotherapy drug.

microscope image of pancreatic cancer--the blue irregular circles on the left--and normal pancreas cells--the smaller circles on the right

Low-Dose Continuous Chemotherapy as Part of a New Combination of Drugs

A clinical trial uses a new immunotherapy drug in combination with standard chemotherapy drugs in metronomic therapy to treat metastatic pancreatic cancer.

microscope image of different cells in shades of green in a fluid

Combining Gene Therapy with Current First-line Treatments for Metastatic Pancreatic Cancer

Gene therapy combined with standard first-line chemotherapy treatment forms a clinical trial for metastatic pancreatic cancer.

microscope image of a cell nucleus and cytoskeleton stained with bright green, blue, and pink

Comparing the Effectiveness of Vaccine Therapy With or Without Additional Immunotherapy

Exploring the effectiveness of the immunotherapy combination of cancer vaccines and a checkpoint blockade drug against metastatic pancreatic cancer.